Health House International

Follow
Get notifications in MyBN when activity occurs. Upgrade your subscription to use this feature.

Health House International (formerly VPCL Limited) was founded in 2016 to pursue opportunities in the burgeoning global medicinal cannabis market.

It is now an ASX-listed international distributor of medicinal cannabis and wholesalers of GMP pharmaceutical products.

In 2019, Health House International acquired HHI (Australia), a business that was granted the first licence in Australia to import and distribute medicinal cannabis. It also acquired P&D Pharmaceuticals, a UK-based speciality pharmaceutical wholesaler which is now trading as Health House Pharma, and supplies a range of pharmaceutical products to pharmacies, hospitals, government departments, ambulance workers and other wholesalers in the UK and EU.

In 2021, Health House International acquired CanPharma GmbH, a privately-held German medicinal cannabis sales and distribution company that holds the highest level of pharmaceutical licences; and also owns Europe’s first medicinal cannabis consultancy Kalapa Clinic (Barcelona).

Also in 2021, following a reverse takeover of VPCL, the company changed its name to Health House International.

Contact Details

Level 3, 101 St Georges Terrace, PERTH WA 6000
08 6558 0886

Company Activity

Tim Slate
NEW ROLE: Tim Slate, Chief Financial Officer, Company Secretary12 Aug 2021
Paul Mavor
NEW ROLE: Paul Mavor, Director, Chief Operating Officer for Australia12 Aug 2021
David Attwood
NEW ROLE: David Attwood, Group Chief Executive12 Aug 2021
Chris Mews
NEW ROLE: Chris Mews, Founder, Non-Executive Director12 Aug 2021
Henrik Sprengel
NEW ROLE: Henrik Sprengel, Executive Director12 Aug 2021
M&A DEAL: New deal has been added12 Aug 2021
Mike Rann
NEW ROLE: Mike Rann, Non-Executive Director12 Aug 2021
David Wheeler
NEW ROLE: David Wheeler, Non-Executive Chair12 Aug 2021
M&A DEAL: New deal has been added19 Jul 2021
ECM DEAL: New deal has been added08 Mar 2021

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options